Search research articles
Contact Us
Filters
Showing results (921-930 of 1,101) with videos related to
Page
of 111
Sort By:
Scientific Reports
|
March 1, 2016
Microfluidic enrichment for the single cell analysis of circulating tumor cells
Trifanny Yeo, Swee Jin Tan, Chew Leng Lim, et al.
Cancer
|
February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis
N Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Nature Materials
|
June 10, 2008
Sidewall oxide effects on spin-torque- and magnetic-field-induced reversal characteristics of thin-film nanomagnets
O Ozatay, P G Gowtham, K W Tan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2021
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study
D S-W Tan, M Thomas, D-W Kim, et al.
JTO Clinical and Research Reports
|
January 13, 2022
Clinical Characteristics and Outcomes in Advanced <i>KRAS</i>-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)
Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2022
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001
Caroline E McCoach, Christian Rolfo, Alexander Drilon, et al.
Breast Cancer Research : BCR
|
June 15, 2018
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Nadine Norton, Nicholas Fox, Christie-Ann McCarl, et al.
Cancer Immunology, Immunotherapy : CII
|
September 28, 2021
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
Yvonne H F Teng, Hong Sheng Quah, Lisda Suteja, et al.
Nature Cardiovascular Research
|
September 11, 2023
Statins improve endothelial function via suppression of epigenetic-driven EndMT
Chun Liu, Mengcheng Shen, Wilson L W Tan, et al.
Developmental Cell
|
August 1, 2024
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors
Shen Yon Toh, Hui Sun Leong, Fui Teen Chong, et al.
Page
of 111
Search research articles
Search
Showing results (921-930 of 1,101) with videos related to
Sort By:
Page
of 111
Scientific Reports
|
March 1, 2016
Microfluidic enrichment for the single cell analysis of circulating tumor cells
Trifanny Yeo, Swee Jin Tan, Chew Leng Lim, et al.
Cancer
|
February 3, 2015
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis
N Gopalakrishna Iyer, Daniel S W Tan, Veronique K M Tan, et al.
Nature Materials
|
June 10, 2008
Sidewall oxide effects on spin-torque- and magnetic-field-induced reversal characteristics of thin-film nanomagnets
O Ozatay, P G Gowtham, K W Tan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2021
Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study
D S-W Tan, M Thomas, D-W Kim, et al.
JTO Clinical and Research Reports
|
January 13, 2022
Clinical Characteristics and Outcomes in Advanced <i>KRAS</i>-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005)
Jiyun Lee, Aaron C Tan, Siqin Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2022
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001
Caroline E McCoach, Christian Rolfo, Alexander Drilon, et al.
Breast Cancer Research : BCR
|
June 15, 2018
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Nadine Norton, Nicholas Fox, Christie-Ann McCarl, et al.
Cancer Immunology, Immunotherapy : CII
|
September 28, 2021
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
Yvonne H F Teng, Hong Sheng Quah, Lisda Suteja, et al.
Nature Cardiovascular Research
|
September 11, 2023
Statins improve endothelial function via suppression of epigenetic-driven EndMT
Chun Liu, Mengcheng Shen, Wilson L W Tan, et al.
Developmental Cell
|
August 1, 2024
Therapeutic application of extracellular vesicular EGFR isoform D as a co-drug to target squamous cell cancers with tyrosine kinase inhibitors
Shen Yon Toh, Hui Sun Leong, Fui Teen Chong, et al.
Page
of 111